Hepatic effects eg, mild, transient transaminase elevations. Symptomatic response to therapy does not preclude presence of gastric malignancy. Consider Zn supplementation in patients prone to Zn deficiency. Co-administration w/ other EDTA-containing IV products. Reports of false +ve urine screening tests for tetrahydrocannabinol in patients receiving PPIs. Use during pregnancy only if clearly needed. Decide whether to discontinue nursing or to discontinue drug, taking into account the benefit of drug to mother. Safety & effectiveness have not been established in ped patients.